PT2429501T - Composições de libertação imediata de fármaco - Google Patents

Composições de libertação imediata de fármaco

Info

Publication number
PT2429501T
PT2429501T PT10720087T PT10720087T PT2429501T PT 2429501 T PT2429501 T PT 2429501T PT 10720087 T PT10720087 T PT 10720087T PT 10720087 T PT10720087 T PT 10720087T PT 2429501 T PT2429501 T PT 2429501T
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
immediate release
immediate
release
pharmaceutical
Prior art date
Application number
PT10720087T
Other languages
English (en)
Inventor
Kinter Kevin
Ramsey Peter
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PT2429501T publication Critical patent/PT2429501T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
PT10720087T 2009-05-13 2010-05-13 Composições de libertação imediata de fármaco PT2429501T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17794309P 2009-05-13 2009-05-13

Publications (1)

Publication Number Publication Date
PT2429501T true PT2429501T (pt) 2019-01-30

Family

ID=42647324

Family Applications (1)

Application Number Title Priority Date Filing Date
PT10720087T PT2429501T (pt) 2009-05-13 2010-05-13 Composições de libertação imediata de fármaco

Country Status (23)

Country Link
US (2) US20100311839A1 (pt)
EP (2) EP2429501B1 (pt)
JP (2) JP5740396B2 (pt)
KR (1) KR101471240B1 (pt)
CN (2) CN107028909A (pt)
AR (1) AR076907A1 (pt)
AU (1) AU2010248979A1 (pt)
BR (1) BRPI1010987B8 (pt)
CA (1) CA2761795C (pt)
CO (1) CO6390100A2 (pt)
ES (1) ES2707275T3 (pt)
HU (2) HUE042857T2 (pt)
IL (1) IL216186B (pt)
MX (1) MX336065B (pt)
NZ (1) NZ596275A (pt)
PL (1) PL2429501T3 (pt)
PT (1) PT2429501T (pt)
RU (2) RU2541807C2 (pt)
SG (2) SG175892A1 (pt)
TR (1) TR201900220T4 (pt)
TW (1) TWI478733B (pt)
WO (1) WO2010132635A1 (pt)
ZA (1) ZA201109084B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
CN109069417B (zh) * 2016-04-26 2022-04-12 Lts勒曼治疗系统股份公司 用于经粘膜施用肽类抗糖尿病药的膜状剂型
CN117017932B (zh) * 2023-08-24 2024-05-24 浙江和沐康医药科技有限公司 一种舒林酸片组合物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4983398A (en) * 1987-12-21 1991-01-08 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
JPH01319416A (ja) * 1988-06-21 1989-12-25 Dai Ichi Kogyo Seiyaku Co Ltd 放出制御可能な錠剤結合剤
JPH05255125A (ja) * 1992-02-29 1993-10-05 Upjohn Co:The 徐放性製剤およびその製法
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US6632451B2 (en) * 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
US20040101494A1 (en) * 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
US20040265373A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet

Also Published As

Publication number Publication date
CO6390100A2 (es) 2012-02-29
BRPI1010987B8 (pt) 2021-05-25
EP2429501A1 (en) 2012-03-21
IL216186A0 (en) 2012-01-31
AR076907A1 (es) 2011-07-20
RU2541807C2 (ru) 2015-02-20
MX2011012045A (es) 2011-12-12
AU2010248979A1 (en) 2011-11-24
RU2014146936A (ru) 2016-06-10
TWI478733B (zh) 2015-04-01
CN102458375A (zh) 2012-05-16
JP5740396B2 (ja) 2015-06-24
KR101471240B1 (ko) 2014-12-09
EP3459530A1 (en) 2019-03-27
US20100311839A1 (en) 2010-12-09
EP2429501B1 (en) 2018-11-21
BRPI1010987B1 (pt) 2020-06-02
RU2011145436A (ru) 2013-06-20
PL2429501T3 (pl) 2019-06-28
TR201900220T4 (tr) 2019-02-21
MX336065B (es) 2016-01-06
EP3459530B1 (en) 2020-09-23
ES2707275T3 (es) 2019-04-03
US20130116327A1 (en) 2013-05-09
IL216186B (en) 2019-10-31
CN107028909A (zh) 2017-08-11
HUE042857T2 (hu) 2019-07-29
WO2010132635A1 (en) 2010-11-18
SG10201402285XA (en) 2014-08-28
CA2761795C (en) 2017-02-21
HUE053202T2 (hu) 2021-06-28
ZA201109084B (en) 2012-08-29
CA2761795A1 (en) 2010-11-18
TW201105367A (en) 2011-02-16
RU2014146936A3 (pt) 2018-06-04
JP2012526841A (ja) 2012-11-01
KR20120012485A (ko) 2012-02-10
JP2015155452A (ja) 2015-08-27
BRPI1010987A2 (pt) 2019-04-02
NZ596275A (en) 2014-01-31
SG175892A1 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
PT2435030E (pt) Composições farmacêuticas flutuantes de libertação controlada
LT3061445T (lt) Labai koncentruotos farmacinės kompozicijos
BRPI1012539A2 (pt) composições farmacêuticas
DK3097925T3 (da) Farmaceutisk sammensætning
DK2395834T3 (da) Natriumnitrit-holdige farmaceutiske sammensætninger
BRPI1004940A2 (pt) composição farmacêutica
BR112012011733A2 (pt) formulações de comprimido de liberação imediata
SMT201600350B (it) Composizioni farmaceutiche
SMT201700095B (is) Composizioni farmaceutiche per inalazione
LT3222272T (lt) Farmacinė karbetocino kompozicija
EP2515946A4 (en) NANOCONJUGATE AND NANOCONJUGATE FORMULATIONS
DK2498756T3 (da) Tabletformuleringer af neratinibmaleat
PT2448582T (pt) Compostos e composições terapêuticas
EP2470605A4 (en) Cured polyhydroxyalkanoate compositions
EP2167043A4 (en) NEW USE CO-CRYSTAL COMPOSITIONS
PT2493478T (pt) Composições terapêuticas concentradas de fosfolípidos
EP2451274A4 (en) Pharmaceutical compositions
LT2966175T (lt) Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato
BRPI1015939A2 (pt) composição farmacêutica
BR112012010201A2 (pt) formulação de libertação modificada da lacosamida
IT1394400B1 (it) Composizioni farmaceutiche
BR112012004525A2 (pt) composição farmacêuticas gástrico-rententivas para liberação imediata ou prolongada de acetaminofeno
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
DK2391351T3 (da) Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater
EP2404987A4 (en) PERFUME COMPOSITIONS